Lilly’s U.S. Plant Flagged; Cathay Cuts 5,300 Jobs: Virus Update

U.S. inspectors found quality-control problems at an Eli Lilly & Co. plant used to help produce its Covid-19 antibody therapy, posing a potential obstacle to the company’s goal of producing 1 million doses by year-end. Cathay Pacific Airways Ltd. will cut about 5,300 jobs as part of a restructuring at the carrier triggered by the pandemic’s hit to travel.